140 related articles for article (PubMed ID: 35094643)
1. Bayesian Divide-and-Conquer Propensity Score Based Approaches for Leveraging Real World Data in Single Arm Clinical Trials.
Baron E; Zhu J; Tang RS; Chen MH
J Biopharm Stat; 2022 Jan; 32(1):75-89. PubMed ID: 35094643
[TBL] [Abstract][Full Text] [Related]
2. Propensity score-integrated power prior approach for incorporating real-world evidence in single-arm clinical studies.
Wang C; Li H; Chen WC; Lu N; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2019; 29(5):731-748. PubMed ID: 31530111
[TBL] [Abstract][Full Text] [Related]
3. Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data.
Liu M; Bunn V; Hupf B; Lin J; Lin J
Stat Med; 2021 Sep; 40(22):4794-4808. PubMed ID: 34126656
[TBL] [Abstract][Full Text] [Related]
4. Covariate handling approaches in combination with dynamic borrowing for hybrid control studies.
Fu C; Pang H; Zhou S; Zhu J
Pharm Stat; 2023; 22(4):619-632. PubMed ID: 36882191
[TBL] [Abstract][Full Text] [Related]
5. Leveraging external evidence using Bayesian hierarchical model and propensity score in the presence of covariates.
Chen X; Yao Y; Wang L; Mukhopadhyay S
Contemp Clin Trials; 2023 Sep; 132():107301. PubMed ID: 37467950
[TBL] [Abstract][Full Text] [Related]
6. Propensity score-integrated Bayesian prior approaches for augmented control designs: a simulation study.
Wang X; Suttner L; Jemielita T; Li X
J Biopharm Stat; 2022 Jan; 32(1):170-190. PubMed ID: 34939894
[TBL] [Abstract][Full Text] [Related]
7. Propensity score-integrated composite likelihood approach for augmenting the control arm of a randomized controlled trial by incorporating real-world data.
Chen WC; Wang C; Li H; Lu N; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2020 May; 30(3):508-520. PubMed ID: 32370640
[TBL] [Abstract][Full Text] [Related]
8. Propensity score-integrated composite likelihood approach for incorporating real-world evidence in single-arm clinical studies.
Wang C; Lu N; Chen WC; Li H; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2020 May; 30(3):495-507. PubMed ID: 31707908
[TBL] [Abstract][Full Text] [Related]
9. Propensity score-integrated approach to survival analysis: leveraging external evidence in single-arm studies.
Chen WC; Lu N; Wang C; Li H; Song C; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2022 May; 32(3):400-413. PubMed ID: 35675348
[TBL] [Abstract][Full Text] [Related]
10. Propensity score-integrated power prior approach for augmenting the control arm of a randomized controlled trial by incorporating multiple external data sources.
Lu N; Wang C; Chen WC; Li H; Song C; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2022 Jan; 32(1):158-169. PubMed ID: 34756158
[TBL] [Abstract][Full Text] [Related]
11. Utility of propensity score-based Bayesian borrowing of external adult data in pediatric trials: A pragmatic evaluation through a case study in acute lymphoblastic leukemia (ALL).
Majumdar A; Rothwell R; Reaman G; Ahlberg C; Roy P
J Biopharm Stat; 2023 Nov; 33(6):737-751. PubMed ID: 36600441
[TBL] [Abstract][Full Text] [Related]
12. A Bayesian nonparametric causal inference model for synthesizing randomized clinical trial and real-world evidence.
Wang C; Rosner GL
Stat Med; 2019 Jun; 38(14):2573-2588. PubMed ID: 30883861
[TBL] [Abstract][Full Text] [Related]
13. Leverage multiple real-world data sources in single-arm medical device clinical studies.
Lu N; Wang C; Chen WC; Li H; Song C; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2022 Jan; 32(1):107-123. PubMed ID: 33844621
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of diagnostic tests for low prevalence diseases: a statistical approach for leveraging real-world data to accelerate the study.
Chen WC; Li H; Wang C; Lu N; Song C; Tiwari R; Xu Y; Yue LQ
J Biopharm Stat; 2021 May; 31(3):375-390. PubMed ID: 33615997
[TBL] [Abstract][Full Text] [Related]
15. Propensity-score-based priors for Bayesian augmented control design.
Lin J; Gamalo-Siebers M; Tiwari R
Pharm Stat; 2019 Mar; 18(2):223-238. PubMed ID: 30537087
[TBL] [Abstract][Full Text] [Related]
16. Ensuring exchangeability in data-based priors for a Bayesian analysis of clinical trials.
Lin J; Gamalo-Siebers M; Tiwari R
Pharm Stat; 2022 Mar; 21(2):327-344. PubMed ID: 34585501
[TBL] [Abstract][Full Text] [Related]
17. Bayesian approaches to include real-world data in clinical studies.
Müller P; Chandra NK; Sarkar A
Philos Trans A Math Phys Eng Sci; 2023 May; 381(2247):20220158. PubMed ID: 36970825
[TBL] [Abstract][Full Text] [Related]
18. Semi-supervised mixture multi-source exchangeability model for leveraging real-world data in clinical trials.
Haine LMF; Murry TA; Nahra R; Touloumi G; Fernández-Cruz E; Petoumenos K; Koopmeiners JS
Biostatistics; 2023 Sep; ():. PubMed ID: 37697901
[TBL] [Abstract][Full Text] [Related]
19. Propensity score stratified MAP prior and posterior inference for incorporating information across multiple potentially heterogeneous data sources.
Zhu AY; Roy D; Zhu Z; Sailer MO
J Biopharm Stat; 2024 Mar; 34(2):190-204. PubMed ID: 36882957
[TBL] [Abstract][Full Text] [Related]
20. Bayesian adaptive randomization design incorporating propensity score-matched historical controls.
Sawamoto R; Oba K; Matsuyama Y
Pharm Stat; 2022 Sep; 21(5):1074-1089. PubMed ID: 35278032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
